Respir Res. 2021 Jan 6;22(1):9. doi: 10.1186/s12931-020-01602-x.
BACKGROUND: It is important to identify deterioration in normotensive patients with acute pulmonary embolism (PE). This study aimed to develop a tool for predicting deterioration among normotensive patients with acute PE on admission.
METHODS: Clinical, laboratory, and computed tomography parameters were retrospectively collected for normotensive patients with acute PE who were treated at a Chinese center from January 2011 to May 2020 on admission into the hospital. The endpoint of the deterioration was any adverse outcome within 30 days. Eligible patients were randomized 2:1 to derivation and validation cohorts, and a nomogram was developed and validated by the aforementioned cohorts, respectively. The areas under the curves (AUCs) with 95% confidence intervals (CIs) were calculated. A risk-scoring tool for predicting deterioration was applied as a web-based calculator.
RESULTS: The 845 eligible patients (420 men, 425 women) had an average age of 60.05 ± 15.43 years. Adverse outcomes were identified for 81 patients (9.6%). The nomogram for adverse outcomes included heart rate, systolic pressure, N-terminal-pro brain natriuretic peptide, and ventricle/atrial diameter ratios at 4-chamber view, which provided AUC values of 0.925 in the derivation cohort (95% CI 0.900-0.946, p < 0.001) and 0.900 in the validation cohort (95% CI 0.883-0.948, p < 0.001). A risk-scoring tool was published as a web-based calculator ( https://gaoyzcmu.shinyapps.io/APE9AD/ ).
CONCLUSIONS: We developed a web-based scoring tool that may help predict deterioration in normotensive patients with acute PE.